Does Propofol Increase Blood Glucose in Burn Patients?
Propofol does not significantly increase blood glucose levels; in fact, it may be associated with slightly lower glucose levels compared to inhalational anesthetics, though it does provide a substantial caloric load (1.1 kcal/mL) that must be accounted for in total nutritional calculations.
Propofol's Metabolic Effects
Propofol is formulated as a lipid emulsion containing 1.1 kcal/mL 1, 2. While this represents a significant non-nutritional calorie source that can contribute to calorie overload when combined with nutritional support 1, propofol itself does not directly elevate blood glucose. Research comparing propofol to inhalational agents (sevoflurane, desflurane) in neurosurgical patients demonstrated that propofol was associated with lower plasma glucose elevations during prolonged procedures 3. In cardiac surgery patients receiving propofol infusions, glucose levels increased perioperatively but this was attributed to surgical stress rather than propofol itself, and importantly, serum lipids did not elevate despite the lipid vehicle 4.
Equivalent D10 Infusion Rate
For every 1 mL/min of propofol infusion, you are delivering approximately 1.1 kcal/min. Since D10 provides 0.34 kcal/mL, this translates to roughly 3.2 mL/min of D10 per 1 mL/min of propofol.
Calculation Example:
- Propofol at 50 mcg/kg/min in a 70 kg patient = 3.5 mg/min = 0.35 mL/min (using 1% propofol = 10 mg/mL)
- Caloric delivery: 0.35 mL/min × 1.1 kcal/mL = 0.385 kcal/min or 23 kcal/hour
- D10 equivalent: 0.385 kcal/min ÷ 0.34 kcal/mL = 1.13 mL/min of D10
For typical ICU sedation doses (25-75 mcg/kg/min), this represents 15-45 kcal/hour of non-nutritional calories that must be subtracted from the patient's prescribed nutritional support 1. Electronic patient data management systems can help track this calorie overload 1.
Glucose Monitoring Frequency
For Non-Diabetic Burn Patients:
Monitor blood glucose every 4-6 hours during propofol infusion, with more frequent monitoring (every 1-2 hours) during the first 24 hours or when adjusting infusion rates.
The rationale:
- Burn patients >20% body surface area are hypermetabolic and at risk for stress hyperglycemia 5
- Target glucose range: 6.0-10.0 mmol/L (108-180 mg/dL) for general ICU patients 6
- For burn patients specifically, maintain glucose at 4.5-8 mmol/L (81-144 mg/dL) with continuous insulin infusion if needed 5
- Non-critically ill patients require pre-meal testing if eating, or every 4-6 hours if NPO 7, 8
For Patients with Prior DKA History:
Monitor blood glucose every 1-2 hours initially, then every 2-4 hours once stable, with immediate testing if any symptoms of hypo- or hyperglycemia occur.
The heightened monitoring is justified because:
- Patients with DKA history have demonstrated β-cell dysfunction and are at higher risk for both hyperglycemia and hypoglycemia 9, 10
- These patients may have impaired counter-regulatory responses
- The combination of critical illness, propofol's caloric load, and potential insulin therapy creates multiple variables affecting glucose
- Any glucose <4.4 mmol/L (<80 mg/dL) requires immediate intervention 11, 12
Critical Monitoring Considerations
During continuous insulin infusion (if required for hyperglycemia), monitor glucose every 30 minutes to 1 hour until stable, then every 1-2 hours 7, 11. The 2024 Society of Critical Care Medicine guidelines emphasize frequent monitoring intervals (≤1 hour) during glycemic instability to minimize hypoglycemia risk 11.
Hypoglycemia Management Protocol:
If glucose drops below 70 mg/dL (100 mg/dL in neurologic injury):
- Stop insulin infusion immediately
- Administer 10-20g of 50% dextrose IV (titrated to initial glucose level)
- Recheck glucose in 15 minutes
- Avoid overcorrection to prevent rebound hyperglycemia 12
Common Pitfalls:
- Failing to account for propofol calories in total nutritional calculations leads to overfeeding 1
- Using capillary glucose from the arm receiving IV fluids may give falsely lower readings 13
- Rapid bolus dextrose administration can cause significant hyperglycemia; a 25g IV dextrose bolus can increase glucose by 162 mg/dL at 5 minutes 12
- Assuming propofol causes hyperglycemia when the actual culprit is surgical stress, inadequate insulin, or concurrent dextrose-containing fluids 3, 14
The key principle: propofol provides calories but not glucose directly—account for its caloric contribution to prevent overfeeding, but monitor glucose based on the patient's underlying metabolic state and diabetes risk, not because of propofol itself.